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Aim
To observe the final adult height of 20 boys with idio-
pathic central precocious puberty (ICPP) treated with
slow-releasing gonadotropin-releasing hormone analo-
gue(GnRHa).
Methods
Twenty boys with ICPP were treated with GnRHa for
(20. 0 ± 6. 1) months. At the beginning of therapy,
mean chronological age and bone age was(11. 4 ± 1. 0)
years and(13. 0 ± 0. 4) years, respectively. GnRHa was
discontinued when the boys reached the chronological
age and bone age of (13. 2 ± 1. 1) years and (13. 7 ± 0.
6) years, respectively. At the conclusion of the study, all
the boys had been followed up for (3. 3 ± 1. 5) years
and had achieved adult height.
Comparisons were made among their predicted adult
height(PAH), final adult height(FAH),and target height
(THt). The long term outcome of final adult height in
boys with ICPP was investigated after GnRHa treatment.
Results
All the boys reached target height range. Final height was
similar to the target height[(169. 8 ± 5. 8) cm vs (167. 8 ±
4. 6)cm, P>0. 05]. The height gain, defined as the differ-
ence between predicted adult height at the start of treat-
ment using the height SDS for bone age and actual adult
height was(3. 62 ± 3. 57)cm with the residual growth capa-
city of(11. 82 ± 3. 99)cm. PAH significantly improved after
GnRHa treatment compared with before treatment [(169.
0 ± 5. 0)cm vs (166. 2 ± 4. 2)cm, P<0. 01]. There were no
differences among PAH, FAH, and THt.
Conclusion
GnRHa treatment can improve final height within the
range of target height in boys with central precocious
puberty.
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